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ABSTRACT 
Phenol compounds, such as propofol and thymol, have been shown to act on the GABAA receptor through 
interaction with specific sites of this receptor. In addition, considering the high lipophilicity of phenols, it is 
possible that their pharmacological activity may be also the result of the interaction of phenol molecules with 
the surrounding lipid molecules modulating the supramolecular organization of the receptor environment. 
Thus, in the present work, we study the pharmacological activity of some propofol- and thymol-related 
phenols on the native GABAA receptor by using primary cultures of cortical neurons, and investigate the 
effects of these compounds on the microviscosity of artificial membranes by means of fluorescence 
anisotropy. The phenol compounds analyzed in this article are carvacrol, chlorothymol and eugenol. All 
compounds were able to enhance the binding of [3H]flunitrazepam with EC50 values in the micromolar range 
and to increase the GABA-evoked Cl- influx in a concentration-dependent manner, both effects  being 
inhibited by the competitive GABAA antagonist bicuculline. These results strongly suggest that the phenols 
studied are positive allosteric modulators of this receptor. Chlorothymol showed a bell-type effect, reducing 
its positive effect at concentrations > 100 μM. The concentrations necessary to induce positive allosteric 
modulation of GABAA receptor were not cytotoxic. Although all compounds were able to decrease the 
microviscosity of artificial membranes, chlorothymol displayed a larger effect, which could explain its effects 
on [3H]flunitrazepam binding and on cell viability at high concentrations. Finally, it is suggested that these 
compounds may exert depressant activity on the central nervous system and potentiate the effects of general 
anesthetics. 
 
KEYWORDS:  
GABAA receptor; Phenol compounds; Neuronal culture; Chloride uptake; Cytotoxicity; Membrane 
interaction; Carvacrol; Eugenol; Chlorothymol; membrane fluidity; fluorescence anisotropy. 
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INTRODUCTION 
γ-Aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the vertebrate central nervous 
system. Altered GABAergic neurotransmission has been involved in many neurological and psychiatric 
disorders such as epilepsy, brain ischemia, schizophrenia, etc. GABAA receptors (GABAA-Rs) are ligand-
gated Cl– ion channels activated by the neurotransmitter GABA and by their agonists such as muscimol or 
isoguvacine, and modulated by numerous therapeutically important drugs, including barbiturates, anesthetics, 
and benzodiazepines. These compounds are allosteric modulators as they bind to sites distinct from the 
GABA binding sites to potentiate GABA-evoked currents. A wide spectrum of drugs, toxic agents and metals 
modify the GABAA-R function by directly interacting either with these binding sites or with other as yet not 
well-described sites present in the receptor complex (1-4).  
General anesthetics are molecules that induce a reversible state of unconsciousness, characterized by amnesia 
and analgesia. Although general anesthetics have been used since the 19th century, their precise mechanism 
of action remains incompletely elucidated. They were originally believed to act via nonspecific interactions 
with the lipid bilayers, affecting membrane fluidity. More recently, general anesthetics have been shown to 
act by modulating ligand-gated ion channels such as the GABAA-R (see references in: (4)). Phenol 
compounds, such as propofol (widely used as a general anesthetic) and thymol, have been shown to act on 
this receptor as allosteric modulators at low concentrations or to have a direct effect on the channel opening at 
higher concentrations. These activities have been described as mediated by their interaction with specific sites 
at the GABAA-R (5, 6). 
However, although specific pharmacological regulation of GABAA-R function can be analyzed using well-
described theories of ligand-receptor interactions, it should be considered that many compounds that regulate 
GABAA-R function are noticeably lipophilic (e.g. benzodiazepines, barbiturates, long-chain alcohols, and 
anesthetics) (7-9), which may change the physical properties of the lipid bilayer. 
Thus, it is possible that the anesthetic activity of lipophilic phenols, as previously mentioned, could be the 
combined result of the interaction of phenol molecules with specific receptor proteins (GABAA-R) and with 
the surrounding lipid molecules modulating the supramolecular organization of the receptor environment (9, 
10). Taking into account not only their lipophilicity but also their conspicuous ability to interact with 
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membranes, demonstrated for phenol compounds (3, 11-15), their contact with the membrane component 
surrounding the receptor and a consequent non-specific effect on receptor modulation cannot be discarded.  
In the present work, we further study the pharmacological activity of some propofol- and thymol-related 
phenols on native GABAA-R by determining their effects on benzodiazepine recognition sites, using primary 
cultures of cortical neurons which express functional GABAA-R (6, 16). Also, we investigate the effects of 
phenol compounds on the microviscosity of artificial membranes (liposomes), in order to deepen the 
understanding of the interaction and location of these compounds in the membrane, by means of fluorescence 
anisotropy. The phenol compounds analyzed are carvacrol, chlorothymol and eugenol (Fig.1) which, together 
with propofol and thymol, were previously studied by our group as regards their lipophilicity, membrane 
partition ability and antioxidant properties (15, 17). The correlation between their pharmacological activities 
and these physical properties is also discussed.  
 
MATERIALS AND METHODS 
Materials 
Fetal calf serum was obtained from Gibco (Glasgow, UK) and Dulbecco’s modified Minimum Essential 
Medium (DMEM) from Biochrom (Berlin, Germany). [3H]Flunitrazepam (88 Ci/mmol) and Na36Cl (0.2 
mCi/mmol) were procured from Amersham Life Sciences (Buckinghamshire, UK) and American 
Radiolabeled Chemicals Inc. (St. Louis, MO, USA), respectively. Liquid scintillation cocktail Optiphase 
Hisafe 2 was obtained from Wallace Oy (Turku, Finland). Carvacrol (2-methyl-5-isopropyl-phenol), eugenol 
(2-methoxy-4-prop-2-enyl-phenol), chlorothymol (5-methyl-4-chloro-2-isopropyl-phenol),  GABA, (-)-
bicuculline methiodide, 1-(4,5-dimethylthiazol-2-yl)-3,5-diphenylformazam (MTT), trypsin, soybean trypsin 
inhibitor, DNAse, amino acids, poly-L-lysine, diphenylhexatriene (DPH) and trimethylammonium-
diphenylhexatriene (TMA-DPH) were obtained from Sigma Chemical Co. (St Louis, MO, USA). 1,2-
dipalmitoyl-phosphatidylcholine (dpPC) was from Avanti Polar Lipids, Inc. (Alabaster, AL, USA). All the 
other chemicals were of analytical grade. All phenols were prepared as 400 mM stock solutions in DMSO, 
light protected, and stored at 4 ºC. Stock solutions were diluted before each experiment in buffered solution, 
maintaining a 0.25% (v/v) DMSO final concentration. 
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Cell cultures 
Primary cultures of cortical neurons were prepared from the cerebral cortices of 16-17 day-old mouse fetuses, 
as previously described (18, 19). Pregnant animals were killed by cervical dislocation and fetuses extracted. 
Neocortices were dissected with forceps, mechanically minced, with cells then dissociated by mild 
trypsinization (0.02% w/v) at 37 ºC for 10 min followed by trituration in a DNAse solution (0.004%-w/v) 
containing a soybean trypsin inhibitor (0.05%-w/v). The cells were re-suspended in a DMEM (5 mM KCl, 31 
mM glucose and 0.2 mM glutamine) supplemented with insulin, penicillin, and 10% fetal calf serum. The cell 
suspension (1.6 x 106 cells/ml) was seeded in 24x-multiwell plates pre-coated with poly-L-lysine, and 
incubated for 6-7 days in a humidified 5% CO2/95% air atmosphere at 36.8 ºC. A mixture of 5 μM 5-fluoro-
2-deoxyuridine and 20 μM uridine was added after 48 h in culture to prevent glial proliferation. 
 
[3H]Flunitrazepam binding 
The benzodiazepine binding to intact cultured cortical neurons was determined as previously described (6) 
using 1.3-2.0 nM [3H]flunitrazepam. Prior to incubation with the radioligand, the plates were washed three 
times with 1 mL/well of HEPES buffer (136 mM NaCl, 5.4 mM KCl, 1.2 mM CaCl2, 1.4 mM MgCl2, 1.0 mM 
NaH2PO4, 10 mM HEPES, and 9 mM glucose adjusted to pH 7.3), and the binding assay took place in the 
culture well in the presence of the HEPES buffer, [3H]flunitrazepam, and drug solutions. After 30 min of 
incubation at 25 ºC without shaking, a cold buffer was added, and rapidly removed by suction. The cells were 
rinsed three times with cold buffer, then they were disaggregated in 0.2 M NaOH overnight, and their 
radioactivity was determined by liquid scintillation counting (with cocktail Optiphase Hisafe2). Basal binding 
was determined in HEPES solution containing 0.25% DMSO in the absence of drugs. Nonspecific binding 
was determined in the presence of 20 μM diazepam. All experiments were run simultaneously with a parallel 
experiment that determined the increase of [3H]flunitrazepam binding induced by 100 μM GABA, used as a 
positive assay control. The GABA stimulation was 198 ± 20% with respect to basal, in agreement with our 
previous report using this type of cultures (6). Bicuculline (100 μM) was used as a GABA antagonist. Data 
are expressed as the percentage of basal specific binding.  
 
Chloride influx 
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GABAA-R potentiation was determined by measuring the 36Cl- uptake in intact cellular cultures (6, 18). 
Briefly, culture medium was replaced by a prewarmed Earle’s balanced salt solution (EBSS: 116 mM NaCl, 
1.8 mMCaCl2, 0.8 mMMgSO4, 1 mMNaH2PO4, 15.2 mM NaHCO3 and 5.5 mM glucose, adjusted to pH 
7.4) and cell cultures were incubated in a humidified 5% CO2/95% air atmosphere at 36.8 ºC. Following 30 
min incubation, buffer was replaced by new EBSS solution and incubated for an additional 15 min. Cells were 
then rinsed twice with EBSS solution and preincubated for 10 min at room temperature. Cultures were 
incubated for 20 s with 225 μl HEPES buffer containing 36Cl- (0.5 μCi/ml), 2 μM GABA and test agents. 
After removing the 36Cl- solution, each well was immediately rinsed three times with 1.5 ml cold HEPES 
solution. Cells were lysed by water-induced hypo-osmotic shock, and radioactivity was determined by liquid 
scintillation counting. Values are normalized with respect to the 36Cl- uptake evoked by 100 μM GABA, as 
this concentration produces the maximum response (18).  
 
Cell Viability 
Following 7 days in vitro, the cells were exposed to different concentrations of each compound for 30 min or 
24 h. Phenols were added after solubilization in 0.2 ml of culture medium previously extracted from each 
well. Cell viability was determined by measuring the reduction of 3-(4,5-methylthiazol-2-yl)-2,5-diphenyl-
2H-tetrazolium bromide (MTT) to a colored formazan salt by mitochondrial reducing activity, as described 
previously (6, 20). Briefly, the cultures were rinsed and incubated for 15 min with a solution of MTT (250 
μg/mL) dissolved in a HEPES buffer solution at 37 ºC. After washing off the excess MTT, the cells were 
disaggregated with 5% SDS, and the colored formazan salt was measured at 560 nm in a spectrophotometer 
plate reader. Data are expressed as a percentage of non-treated cultures. 
 
Large unilamellar vesicles (LUVs) formation 
Multilamellar vesicles (MLVs) were prepared as described elsewhere with modifications (21). Briefly, a dry 
film was obtained by evaporating, under a stream of N2, a chloroformic solution of pure dpPC. The dried lipid 
was resuspended in bidistilled water by vigorous shaking for 1 min at room temperature. The MLVs obtained 
were passed 19 times through a 0.1 μm cellulose filter using a Liposofast mini-extruder (Avestin Inc., Ottawa, 
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ON, Canada), in order to obtain LUVs of a homogeneous size with diameters around 100 nm. The LUVs were 
always used immediately after their preparation. 
 
Steady-state fluorescence 
The fluorescent probes DPH (2 μM) and TMA-DPH (6 μM) were added to the dpPC LUVs suspension 
prepared as described above and incubated for 1 h at room temperature. The effects of phenol compounds on 
the DPH and TMA–DPH steady-state fluorescence anisotropy were studied.  
Anisotropy values were calculated from the emission fluorescence intensities at λ emission = 430 nm (λ 
excitation = 356 nm) measured with the excitation and the sample polarizer filters oriented parallel and 
perpendicularly with respect to each other, in a L-format FluoroMax-3 spectrofluorometer (Jovin Yvon, 
Horiba). Steady-state fluorescence anisotropy (A) was calculated as 
A = (VV – VH.G) / VV + 2.VH.G ,  G = HV/HH    (1) 
where VV, HH, VH and HV are the values of the different measurements of fluorescence intensity, taken with 
both polarizers in vertical (VV) and horizontal (HH) orientations or with excitation polarizer vertical and 
emission polarizer horizontal (VH) or vice versa (HV). G is a correction factor for differences in sensitivity of 
the detection system for vertically and horizontally polarized light (22). 
 
Data analysis 
Data shown represent the mean ± standard error of mean (SEM). Sigmoid curves were fitted to concentration 
response data and statistical analyses were performed using GraphPad Prism (GraphPad Software Inc, San 
Diego, CA, USA). A two-tailed Student’s t-test, as well as one-way and two-way analysis of variance 
(ANOVA), were used. 
 
RESULTS  
It has been previously reported that an increase of [3H]flunitrazepam binding corresponds to potentiation of 
the GABAA-R (6, 23, 24). Fig. 2 shows the concentration-response curve of the effects of phenol compounds 
on specific [3H]flunitrazepam binding in primary cultures of cortical neurons. Carvacrol and eugenol induced 
a concentration-dependent increase in specific binding, with EC50 values of 235 μM and 532 μM, and 
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maximum responses (Emax) of 195% and 166% with respect to basal condition (100%), respectively (Table 1). 
Chlorothymol exerted an enhancement of the specific binding, but only until around 100 μM, showing a 
response of 146% with respect to basal. Higher concentrations of chlorothymol reduced the binding to values 
lower than the basal binding. Therefore, calculation of the EC50 value took into account concentrations up to 
100 μM (Table 1). Increases in [3H]flunitrazepam binding induced by stimulant concentrations of each phenol 
were completely inhibited by the competitive GABAA-R antagonist bicuculline (Fig 3). The non-significant 
decrease of about 25% with respect to the control binding induced by bicuculline was in accordance with 
bicuculline responses reported previously (9, 25). To confirm that these phenolic compounds act as positive 
allosteric modulators of the GABAA-R, we tested their effects on GABA-evoked chloride influx. Fig. 4 shows 
that these compounds increased the GABA-evoked Cl- influx in a concentration-dependent manner. 
Furthermore, 100 μM bicuculline significantly reversed this increase. When compounds were tested alone in 
the absence of GABA, they did not induce an influx of Cl- (data not shown).  
Fig. 5 shows the effects of phenols on cell viability in primary neuronal cultures determined by the capability 
of the live cells to reduce the MTT salt. The concentrations assayed for each compound were selected 
considering ranges that include stimulant concentrations on [3H]flunitrazepam binding. Thus, the ranges used 
were 100-1000 μM for carvacrol, 400-2000 μM for eugenol and 10-200 μM for chlorothymol. The phenolic 
compounds assayed did not reduce cell viability after exposure of cortical neurons for 30 min (time period of 
the binding assay). Increasing the exposure time up to 24 h, carvacrol did not affect cell viability, while 
eugenol and chlorothymol showed negative effects (although non-significant with respect to the control) at 
the highest concentrations tested (2000 μM and 200 μM, respectively).  
Anisotropy values for DPH and TMA-DPH in dpPC LUVs were evaluated as a function of temperature (36-
45 ºC) in the presence of different phenolic compound concentrations (0-200 μM) (Fig. 6). The temperature 
dependences of DPH and TMA-DPH fluorescence anisotropy in control samples containing dpPC (without 
any phenol compound) showed an abrupt change at approximately 41.5 ºC, in agreement with the phase 
transition of dpPC (26). All phenol compounds induced changes at this temperature transition, moving it 
toward lower temperatures, and this effect was concentration-dependent.  Comparatively, chlorothymol 
produced the greater changes, according to its higher lipophilicity (15). Fig. 7 shows the fluorescence 
anisotropy values of both probes (DPH and TMA-DPH), taken from data of Fig. 6 and plotted as a function of 
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compound concentration at constant temperature (≈ 38.5 ºC). These results indicate that, while carvacrol and 
eugenol affect the fluorescence anisotropy of both probes in the same way, chlorothymol produced a more 
marked effect on the DPH probe.  
 
DISCUSSION 
The phenolic compounds here studied potentiated the specific binding of flunitrazepam, and this effect was 
saturable, reaching a maximal value (Emax) with carvacrol and eugenol. The GABAA antagonist bicuculline 
blocked the effect. Thus, the phenolic agents produced their effects on a site of the receptor different from that 
of flunitrazepam, thereby modifying receptor binding with this ligand. These compounds, therefore, appear to 
act as allosteric activators of benzodiazepine binding sites on the GABAA-R that indirectly modulate the 
activity of the receptor (16, 27, 28).  It should be noted that these allosteric sites are the targets of many 
neuroactive drugs, including benzodiazepines, propofol, barbiturates, inhaled anesthetics and ethanol, among 
others. We have previously reported that the release of endogenous GABA from cultured cortical neurons 
exposed to basal conditions resulted in a GABA concentration in the medium of around 34 nM (6). This 
concentration does not elicit GABAA-R-mediated responses (29-31). For this reason, the stimulations 
obtained in our experiments are considered to be exerted by each compound specifically. 
Carvacrol is a monoterpenic phenol present in numerous aromatic plants, such as oregano (Origanum 
vulgare), thyme (Thymus vulgaris), and wild bergamot (Monarda fistulosa) (32). It is used on a large scale in 
the food and cosmetic industries, and is a common ingredient of the human diet (33). It has been reported that 
carvacrol has an analgesic action (34), anti-acetylcholinesterase (AChE) activity (35) and an anxiolytic-like 
effect (36). The latter report suggests the involvement of the GABAergic system in the anxiolytic effect, 
demonstrated by means of behavioral tests. Our results support this hypothesis, since carvacrol, like eugenol, 
was able to induce an increase in the binding of the GABAA-R allosteric modulator flunitrazepam, with this 
effect also being hindered by the antagonist bicuculline. Furthermore, the EC50 obtained for this stimulant 
effect of carvacrol (235 μM) is comparable to the doses used by Melo et al. (36) in in vivo experiments to 
induce an anxiolytic effect (25-50 mg/Kg ≈ 167-333 μM). Also, carvacrol was more potent as a GABAA-R 
modulator (EC50: 235 μM; this work) than as an AChE inhibitor (IC50: 400 μM; (35)).  
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Eugenol is an aromatic compound that is commonly contained in various sorts of plants, especially in spices 
and medicinal herbs (clove, nutmeg, cinnamon, etc). It is extensively used in dental procedures for analgesic 
and antiseptic purposes (37, 38).  Its effects on the nervous system have been widely studied (see refs in (39)). 
Eugenol is neuroprotective against excitotoxicity, ischemia and amyloid-β peptide (40-42), induces 
anaesthesia in rats (43), restrains epileptiform field potentials and spreading depression in hippocampus and 
neocortex (44), inhibits Na+ currents as a mechanism of analgesia (39), inhibits N-methyl-D-aspartate 
(NMDA) receptors and potentiates GABAA-R in mammals (41, 45). In the present work, we further 
demonstrate that eugenol is a positive GABAA-R modulator. The EC50 value obtained for this positive effect 
(530 μM) is very close to the eugenol concentration used by Aoshima and Hamamoto (45), (650 μM) to 
potentiate GABAA-R responses. The fact that the increase in [3H]flunitrazepam binding induced by eugenol 
was inhibited by bicuculline corroborates its positive modulation of the GABAA-R. Compared with the 
known bactericide activity of carvacrol and eugenol at concentrations in the range of 1 - 10 mM (46-48), our 
results demonstrate that their active concentrations on GABAA-R (EC50 235 and 532 μM, respectively) for the 
stimulation of flunitrazepam binding are orders of magnitude lower than those found to be active against 
bacteria.  
The inclusion of chlorothymol in the present study is justified by its phenolic structure, similar to that of 
thymol, which showed important GABAergic activity (see (6, 16) and refs) with a halogen atom (Cl) bound to 
the phenolic ring. It is used in cosmetics and personal care products. We have no knowledge until now of 
studies of chlorothymol’s effects on the nervous system. Thus, its effect on GABAA-R reported here and its 
inhibition by a GABAA antagonist would be the first description of a possible pharmacological activity in the 
central nervous system.  The shape of the concentration-response curve and the decline in activity at higher 
concentrations may be accounted for by the introduction of a Cl atom in the molecule and the increased 
toxicity of this compound.  
Our results showing the effects of carvacrol, eugenol and chlorothymol on the GABAA-R also have 
pharmacological implications for drug safety in clinical practice. The widespread use of herbal products and 
phytomedicines containing the phenolic compounds considered here raises the issue of the potential effects 
deriving from their concomitant use with commonly prescribed drugs with Central Nervous System effects.  
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Carvacrol-containing products are mostly purchased at herbal medicine and health food stores or over the 
Internet (49). Nowadays the most commonly advertised so-called natural medicines are preparations of 
essential oils of oregano with concentrations of carvacrol in the range of 75-85%.  These oils are marketed as 
either a liquid or as capsules for oral administration, and it can be calculated that, at the usual dosage 
recommended, the carvacrol dose ranges between 100-200 mg/day. Extrapolating from the experimental data, 
at these doses carvacrol might induce GABAergic effects. The interaction of carvacrol with prescribed 
psychoactive drugs acting on the GABAA-R might increase the inhibitory activity of benzodiazepines, 
barbiturates, propofol, etc. The interaction of this agent with perioperative patient care may be of particular 
importance, as has been reported with other herbal medicines (50-52). Thus, for example, interaction with 
propofol, the most commonly used parenteral anesthetic, would increase the time of sedation and the 
operative patient management, given that propofol acts primarily through enhancement of GABAA-R 
function, as carvacrol seems to do. Moreover, one of the main concerns with these herb-drug interactions is 
that patients do not usually report to their doctors that they are taking the herbal medicines (50, 53-56). 
As regards eugenol, although essential oils of clove (Syzygium aromaticum) and other spices are also 
marketed, they are mostly intended for topical use. However, there are large populations (millions of people) 
exposed to eugenol through the smoke of specific cigarettes. This is the case of Indonesian clove-flavored 
cigarettes (kreteks), which contain levels of eugenol in their smoke ranging from 2.4 to 38 mg/cigarette (57).  
A similar case is that of Indian bidi cigarettes, which consist of tobacco wrapped in tendu leaf plants 
(Diospyros malanoxylon). Kreteks and bidis are gaining popularity among young people in Western countries 
(58).  
We previously developed a pharmacophoric hypothesis for the binding site of propofol-analogue phenolic 
compounds in the GABAA-R (6). This hypothesis includes three hydrophobic aliphatic features, one hydrogen 
bond donor group, an exclusion volume, and an aromatic ring. We demonstrated the possible alignments of 
propofol and thymol using that hypothesis. Carvacrol can clearly accommodate most of the features described 
in the proposed hypothesis, whereas eugenol would not entirely fit the model due to the substitution of an 
aliphatic group by the polar methoxy group in position 2. The present results support the previously reported 
pharmacophoric hypothesis, in which the better fit of carvacrol compared to eugenol would justify their 
different potency at the GABAA-R found in this work (EC50: 235 μM and 532 μM, respectively). On the other 
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hand, although chlorothymol showed a significant lower EC50 value (19 μM) similar to that of propofol (25 
μM)(59), its pharmacological activity could be considered more limited by their inhibitory effects at high 
concentrations. 
An important characteristic of phenol compounds is their hydrophobicity, which enables them to partition in 
the lipids of the cell membrane (15). This partition can disturb the cell structures rendering them more 
permeable, permitting the leakage of ions and other cell contents (47). However, none of the phenolic 
compounds was able to significantly induce the release of hemoglobin from red blood cells until 1 mM 
(chlorothymol) and 2 mM (carvacrol and eugenol) (results not shown). The hemolysis is a suitable method to 
measure membrane permeability as it was previously reported (see (60) and refs.). In addition, we recently 
demonstrated that the velocity of penetration of these compounds in phospholipid model membranes was 
quite similar (61) in spite of the fact that their partition ability was different (15). Both results would indicate 
that the compounds do not strongly affect cell permeability and that other different mechanisms would be 
involved in the loss of pharmacological activity induced by chlorothymol concentrations over 100 μM and in 
the eventual neurotoxic effects showed by chlorothymol (200 μM) and eugenol (2 mM) at 24 h with the MTT 
assay.   
Fluorescence anisotropy gives information about the organization of the membrane environment around the 
fluorescent probe. DPH is known to be located within the hydrocarbon chain region of the membrane core, 
while TMA-DPH, due to its polar ionic portion, is located near the interfacial region in the polar head group 
region (62). The complex structural dynamics of the bilayers is governed by temperature-dependent 
parameters such as the average interfacial area per lipid, thickness of bilayer, and disorder of hydrophobic 
tails, which determine its phase behavior. For saturated phosphatidylcholines, such as dpPC, the main 
transition between the liquid-crystalline phase (La) and the gel phase (gel-fluid transition) occurs at 41.5 ºC 
(26, 63). In the present work, all compounds reduced their transition phase temperature, as revealed by the 
occurrence, for both fluorescent probes, of an anisotropy reduction at lower temperatures in a concentration-
dependent manner. This effect seems to indicate a fluidizing effect on the membrane by decreasing molecular 
order and mobility throughout the bilayer thickness. However, these results were more marked in the presence 
of chlorothymol, which is to be expected considering its higher lipophilicity. We previously demonstrated a 
superior partition coefficient (logP) in the dpPC liposome-buffer system for chlorothymol with respect to 
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carvacrol and eugenol (logP values: 3.54, 2.48 and 1.89, respectively) (15). Furthermore, in spite of the fact 
that all compounds affected the anisotropy of both probes used, carvacrol and eugenol showed a similar effect 
on the mobility of DPH and TMA-DPH, while chlorothymol more essentially affected the dynamics at the 
hydrocarbon chain region, demonstrated by the strong reduction in the DPH anisotropy. This would indicate 
its special preference for a location in the core of the membrane where the hydrophobicity is much more 
obvious, causing changes in the physical properties of the cytoplasmic membrane. Thus, the results presented 
in Figs. 6 and 7 suggest that the comparatively higher ability of chlorothymol to interact with membranes may 
be responsible for the larger effect against neuron viability since the concentrations of chlorothymol and 
eugenol needed to reach similar deleterious effects (a loss of cell viability around 25% after 24 h of exposure) 
differ by an order of magnitude (0.2 mM and 2 mM, respectively). Considering that GABAA-R function can 
be regulated by lipid bilayer elasticity, which is affected by amphiphiles partition (3), this hypothesis may 
also explain the rapid loss of activity described for [3H]flunitrazepam binding at chlorothymol concentrations 
over 100 μM. Respect to the modulation of the GABAA-R by the physical state of the membrane, it has been 
reported that  the functions of proteins in the membrane might be altered as a result of the bilayer properties 
like elasticity, fluidity, thinning, etc. Because of the hydrophobic interactions between a membrane protein 
transmembrane region and the lipid bilayer core, a protein conformational change that involves the protein-
bilayer hydrophobic interface can cause a local bilayer deformation (3, 10, 64).   
Taking into account: i) the structural similarity between the compounds assayed with thymol and propofol, a 
widely proved general anesthetic (see refs. in (2)) and, ii) the effects presented here on the GABAA-R, we 
may strongly suggest a sedative activity for carvacrol, eugenol and chlorothymol. This hypothesis is 
supported for eugenol, the anesthetic effect of which has been already reported in in vivo experiments (43, 
65).   
In conclusion, we have found that carvacrol, eugenol and chlorothymol were able to enhance the binding of 
[3H]flunitrazepam at the GABAA-R and the GABA-evoked Cl- influx, both effects being inhibited by the 
competitive GABAA-R antagonist bicuculline. These results strongly suggest that the phenols studied are 
positive allosteric modulators of the GABAA-R. The concentrations necessary to induce positive allosteric 
modulation of GABAA-R are not neurotoxic. Furthermore, they are much lower than those reported to elicit 
bactericide activity. Although all compounds were able to decrease the microviscosity of artificial 
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membranes, chlorothymol displayed a greater effect, which may explain its cytotoxic action at high 
concentrations. It is suggested that these compounds may exert depressant activity on the central nervous 
system and could potentiate the effects of general anesthetics.  
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LEGENDS OF FIGURES 
 
Figure 1. Chemical structures of the phenolic compounds analyzed. Propofol and thymol are included for 
comparison. 
Figure 2. Concentration-response curves for [3H]flunitrazepam binding in the presence of carvacrol, 
eugenol and chlorothymol. [3H]Flunitrazepam binding was performed in intact cultured cortical neurons at 
25 ºC for 30 min. Results are expressed as the percentage of basal binding (bas) (100 %) in the absence of the 
test agent. Each point represents the mean ± S.E.M. of 3-4 independent experiments, each performed in 
triplicate.  
 
Figure 3. Effects of bicuculline on the increase of [3H]flunitrazepam binding induced by phenolic 
compounds. Bas: basal samples (in absence of any phenolic compound), Carv: carvacrol (500 ?M), Eug: 
eugenol (900 ?M) and Chlor: chlorothymol (100 ?M). The bars correspond to mean ± S.E.M. of 2 - 3 
experiments done in triplicate in the absence (black bars) or in the presence of 100 ?M bicuculline (gray 
bars), and represent the percentage with respect to the basal (100 %). * and **: p < 0.01 and p < 0.001, 
respectively, vs basal in the absence of bicuculline; #,## and ###: p < 0.05, p < 0.01 and p < 0.001, 
respectively, vs the same treatment in the absence of bicuculline (two- way ANOVA).  
 
Figure 4. Effect of carvacrol, eugenol and chlorothymol on GABA-evoked Cl- influx. 36Cl- uptake was 
performed in intact cultured cortical neurons exposed to 2μM GABA and different concentrations (in 
micromolar) of carvacrol (Carv), eugenol (Eug) and chlorothymol (Chlor). Control cells (Ctr) were exposed 
to 2μM GABA and vehicle. Values were normalized to the maximum Cl- influx evoked by 100 μM GABA. 
The bars correspond to mean ± SEM (n = 6 – 8 from two independent experiments). 100 μM bicuculline (gray 
bars) reversed the effect of the highest tested concentration of thymol-analogues.  * and **: p < 0.05 and p < 
0.01, respectively, vs control in the absence of bicuculline;  # and &: p < 0.05 and p < 0.001, respectively, vs 
the same treatment in the absence of bicuculline (two- way ANOVA).  
 
Figure 5. Cell viability MTT assay in the presence of phenolic compounds. All values are mean S.E.M. of 
3-6 independent experiments done in triplicate. The bars represent the percentage of cell viability with respect 
to 100% control (without any phenol) after 30 min (black bars) or 24 h (gray bars) of exposure to each 
compound. 
 
Figure 6. Effects of phenol compounds on temperature dependence of DPH and TMA-DPH 
fluorescence anisotropy. Fluorescence anisotropy of DPH (left panels) and TMA-DPH (right panels) as a 
function of temperature in DPPC LUVs containing phenol compounds at different concentrations: 0 (■), 50 
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(▲), 100 (▼) and 200 μM (♦). A-B) Carvacrol, C-D) eugenol and E-F) chlorothymol. The anisotropy values 
were normalized, considering the value corresponding to the lower temperature assayed in the absence of any 
phenol compound as equal to unit.  
 
Figure 7. Effects of phenol compounds on fluorescence anisotropy at constant temperature. 
Fluorescence anisotropy of DPH (■) and TMA-DPH (□) in DPPC LUVs containing phenol compounds at 
different concentrations (0, 50 100 and 200 μM) at ≈38.5 °C. A) carvacrol, B) eugenol and C) chlorothymol. 
Normalized values correspond to Fig. 6.  
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
ge
Figure 2
Click here to download high resolution image
ge
ge
Figure 5
Click here to download high resolution image
ge
Figure 7
Click here to download high resolution image
Table 1.  
Effects of phenol compounds on [3H]flunitrazepam binding in primary cultures of cortical neurons. 
 
 
        Log EC50   EC50 (μM) Emax (%) 
     
 
Carvacrol  -3.760 ± 0,271     235    195 ± 36 
Eugenol   -3,291 ± 0,071     532    166 ± 14 
Chlorothymol*  -5,128 ± 0,365        19    146 ± 17 
 
The values correspond to the mean ± S.E.M. of 3-4 independent experiments, each performed in 
triplicate. A minimum of 6 concentrations were used for each curve. EC50 values were calculated as 
explained in the Material and Methods section. Emax corresponds to the percentage increase with respect to 
the basal binding. * Chlorothymol data were fit to sigmoidal curve up to 100 μM. 
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